Derek Amanatullah

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Derek Amanatullah sits in the upper half of US sponsors by registered trial count (#4,885 of 15,742 sponsors by registered trial count).

2 total trials none currently recruiting 1 completed upper half by trial count

Derek Amanatullah: 2 sponsored US clinical trials, none currently recruiting.

Derek Amanatullah sponsors 2 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 1 completed. The most-studied condition in this pipeline is Total Joint Replacement Surgery, with 1 trials.

Mid-pack sponsor footprint

Derek Amanatullah is in the upper half of sponsors by trial count (#4,885 of 15,742 sponsors by registered trial count). Use the pipeline list and therapeutic areas to see what drives that mid-pack volume.

How the Derek Amanatullah archive is shaped

2 indexed studies, none listed as recruiting (0% open); 1 completed (50%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Total Joint Replacement Surgery (1 trial), 0 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Derek Amanatullah: archived-pipeline peers nationwide

Peers matched on 2 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Derek Amanatullah sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%20%40%60% Total trials Recruiting share Derek Amanatullah1200 Pharma1ST Biotherapeutics3 Waves Wellness3EO Health10xBio22nd Century Group23andMe3-C Institute for Social Development
Derek Amanatullah sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Derek Amanatullah sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 2 archived trials

Sponsors with similar archive density (± trial count)

What to do with this Derek Amanatullah page

2 registered trials is a research-attention snapshot, not an endorsement of Derek Amanatullah or any single study.

  • None of Derek Amanatullah's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Total Joint Replacement Surgery is the condition Derek Amanatullah studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Total Joint Replacement Surgery trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Derek Amanatullah pipeline card: 2 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.